In the context of experimental autoimmune encephalomyelitis (EAE), it has been shown that B-cell depletion therapy ameliorates central nervous system (CNS) inflammation through ablation of pathogenic IL-6-producing B lymphocytes39. This evidence concerns the gene IL6 and experimental autoimmune encephalomyelitis.